VIDEO: Oil Stocks: Buy Here or Stay Clear?
Barron’s writer Ben Levisohn discusses the opportunities and risks in crude’s recent slide.
Read MoreBarron’s writer Ben Levisohn discusses the opportunities and risks in crude’s recent slide.
Read MoreTough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.
Read MoreWe use cookies to improve your experience. You can choose which types of cookies to accept. Read our Privacy Policy.
Choose which cookies to enable: